Caraceni T, Scigliano G, Musicco M
Neurological Institute C. Besta, National Research Council-Institute of Advanced Biomedical Technologies, Milan, Italy.
Neurology. 1991 Mar;41(3):380-4. doi: 10.1212/wnl.41.3.380.
The aim of this study is to evaluate what factors influence the risk of occurrence of motor fluctuations in patients with Parkinson's disease (PD) with particular reference to the role of early or delayed introduction of levodopa therapy during the course of the disease. One hundred twenty-five consecutive newly diagnosed patients with PD started levodopa treatment at the time diagnosis and were followed for 2 to 10 years. During follow-up, 60 patients had wearing-off or early morning akinesia. We estimated the cumulative time-dependent risk of motor fluctuation occurrence through a multivariable analysis. The risk was lower for patients with tremor-predominant PD, for those with shorter disease duration prior to levodopa, and for those who were relatively older at levodopa initiation. Our results suggest that, as far as motor fluctuations are concerned, disease prognosis is not influenced by early levodopa treatment. These observation support the introduction of levodopa as soon as there is a subjective need for the patients to maintain their level of social and work performance.
本研究的目的是评估哪些因素会影响帕金森病(PD)患者出现运动波动的风险,特别提及疾病过程中左旋多巴治疗的早期或延迟引入所起的作用。125例连续新诊断的PD患者在确诊时开始左旋多巴治疗,并随访2至10年。随访期间,60例患者出现剂末现象或清晨运动不能。我们通过多变量分析估计了运动波动发生的累积时间依赖性风险。以震颤为主的PD患者、左旋多巴治疗前病程较短的患者以及开始使用左旋多巴时年龄相对较大的患者,其风险较低。我们的结果表明,就运动波动而言,疾病预后不受早期左旋多巴治疗的影响。这些观察结果支持在患者主观上有需要维持其社交和工作表现水平时尽早引入左旋多巴。